BlackRock’s Design Therapeutics DSGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.07M | Sell |
2,395,743
-84,220
| -3% | -$284K | ﹤0.01% | 3470 |
|
|
2025
Q1 | $9.57M | Sell |
2,479,963
-99,636
| -4% | -$385K | ﹤0.01% | 3300 |
|
|
2024
Q4 | $15.9M | Buy |
2,579,599
+220,802
| +9% | +$1.36M | ﹤0.01% | 3143 |
|
|
2024
Q3 | $12.7M | Buy |
2,358,797
+53,849
| +2% | +$290K | ﹤0.01% | 3242 |
|
|
2024
Q2 | $7.72M | Buy |
2,304,948
+30,757
| +1% | +$103K | ﹤0.01% | 3468 |
|
|
2024
Q1 | $9.16M | Sell |
2,274,191
-106,051
| -4% | -$427K | ﹤0.01% | 3336 |
|
|
2023
Q4 | $6.31M | Sell |
2,380,242
-23,673
| -1% | -$62.7K | ﹤0.01% | 3527 |
|
|
2023
Q3 | $5.67M | Sell |
2,403,915
-590,136
| -20% | -$1.39M | ﹤0.01% | 3552 |
|
|
2023
Q2 | $18.9M | Sell |
2,994,051
-191,840
| -6% | -$1.21M | ﹤0.01% | 3012 |
|
|
2023
Q1 | $18.4M | Sell |
3,185,891
-322,133
| -9% | -$1.86M | ﹤0.01% | 2961 |
|
|
2022
Q4 | $36M | Sell |
3,508,024
-91,101
| -3% | -$935K | ﹤0.01% | 2651 |
|
|
2022
Q3 | $60.2M | Buy |
3,599,125
+59,189
| +2% | +$990K | ﹤0.01% | 2282 |
|
|
2022
Q2 | $49.6M | Buy |
3,539,936
+389,116
| +12% | +$5.45M | ﹤0.01% | 2470 |
|
|
2022
Q1 | $50.9M | Buy |
3,150,820
+935,196
| +42% | +$15.1M | ﹤0.01% | 2539 |
|
|
2021
Q4 | $47.4M | Buy |
2,215,624
+902,960
| +69% | +$19.3M | ﹤0.01% | 2658 |
|
|
2021
Q3 | $19.3M | Sell |
1,312,664
-90,678
| -6% | -$1.33M | ﹤0.01% | 3251 |
|
|
2021
Q2 | $27.9M | Buy |
1,403,342
+612,323
| +77% | +$12.2M | ﹤0.01% | 3049 |
|
|
2021
Q1 | $23.7M | Buy |
+791,019
| New | +$23.7M | ﹤0.01% | 3040 |
|